Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetofetal Transfusion | 33 | 2024 | 185 | 8.350 |
Why?
|
| Fetoscopy | 35 | 2024 | 425 | 4.170 |
Why?
|
| Fetal Diseases | 11 | 2024 | 443 | 3.500 |
Why?
|
| Pregnancy | 81 | 2024 | 7092 | 2.950 |
Why?
|
| Ultrasonography, Prenatal | 25 | 2024 | 901 | 2.920 |
Why?
|
| Pregnancy, Twin | 28 | 2024 | 168 | 2.690 |
Why?
|
| Laser Therapy | 10 | 2023 | 245 | 2.000 |
Why?
|
| Fetus | 13 | 2023 | 579 | 1.980 |
Why?
|
| Fetal Growth Retardation | 8 | 2024 | 216 | 1.900 |
Why?
|
| Anemia | 4 | 2023 | 338 | 1.830 |
Why?
|
| Premature Birth | 13 | 2023 | 380 | 1.760 |
Why?
|
| Gestational Age | 32 | 2024 | 1115 | 1.730 |
Why?
|
| Blood Transfusion, Intrauterine | 4 | 2024 | 37 | 1.570 |
Why?
|
| Meningomyelocele | 7 | 2024 | 222 | 1.520 |
Why?
|
| Neural Tube Defects | 7 | 2024 | 351 | 1.400 |
Why?
|
| Pregnancy Outcome | 18 | 2024 | 592 | 1.260 |
Why?
|
| Laser Coagulation | 11 | 2024 | 128 | 1.260 |
Why?
|
| Infant, Newborn | 34 | 2024 | 8096 | 1.230 |
Why?
|
| Retrospective Studies | 45 | 2024 | 15853 | 1.190 |
Why?
|
| Female | 82 | 2024 | 64883 | 1.150 |
Why?
|
| Rh Isoimmunization | 2 | 2024 | 28 | 1.130 |
Why?
|
| Pregnancy Complications | 2 | 2022 | 503 | 1.120 |
Why?
|
| Urethral Obstruction | 3 | 2023 | 56 | 1.110 |
Why?
|
| Fetal Death | 5 | 2023 | 115 | 1.040 |
Why?
|
| Teratoma | 2 | 2024 | 125 | 1.040 |
Why?
|
| Twins, Monozygotic | 10 | 2023 | 109 | 0.980 |
Why?
|
| Umbilical Arteries | 4 | 2021 | 90 | 0.970 |
Why?
|
| Sacrococcygeal Region | 1 | 2024 | 32 | 0.950 |
Why?
|
| Diseases in Twins | 2 | 2021 | 93 | 0.930 |
Why?
|
| Pleural Effusion | 1 | 2024 | 99 | 0.890 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 4 | 2023 | 381 | 0.870 |
Why?
|
| Amniotic Fluid | 5 | 2024 | 147 | 0.840 |
Why?
|
| Placenta Previa | 1 | 2023 | 63 | 0.820 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 50 | 0.820 |
Why?
|
| Prenatal Diagnosis | 4 | 2024 | 580 | 0.820 |
Why?
|
| Spinal Dysraphism | 3 | 2023 | 262 | 0.820 |
Why?
|
| Humans | 82 | 2024 | 122296 | 0.800 |
Why?
|
| Fetal Therapies | 3 | 2020 | 72 | 0.790 |
Why?
|
| Walking | 2 | 2024 | 197 | 0.790 |
Why?
|
| Magnesium Sulfate | 2 | 2021 | 51 | 0.780 |
Why?
|
| Polycythemia | 3 | 2024 | 42 | 0.770 |
Why?
|
| Cerebral Ventricles | 2 | 2024 | 81 | 0.760 |
Why?
|
| Adult | 33 | 2024 | 28733 | 0.750 |
Why?
|
| Ascites | 1 | 2021 | 88 | 0.740 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2020 | 48 | 0.710 |
Why?
|
| Anemia, Neonatal | 1 | 2019 | 8 | 0.690 |
Why?
|
| Anemia, Hemolytic | 1 | 2019 | 31 | 0.680 |
Why?
|
| Prospective Studies | 13 | 2023 | 5963 | 0.670 |
Why?
|
| Hysterotomy | 4 | 2024 | 118 | 0.660 |
Why?
|
| Spectrin | 1 | 2019 | 63 | 0.650 |
Why?
|
| Pregnancy Reduction, Multifetal | 4 | 2022 | 21 | 0.610 |
Why?
|
| Ultrasonography, Doppler, Color | 2 | 2019 | 58 | 0.610 |
Why?
|
| Placenta | 7 | 2023 | 487 | 0.600 |
Why?
|
| Lower Extremity | 1 | 2019 | 178 | 0.600 |
Why?
|
| Anesthetics, Inhalation | 1 | 2018 | 46 | 0.590 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 428 | 0.540 |
Why?
|
| Cohort Studies | 11 | 2024 | 4643 | 0.530 |
Why?
|
| Perinatal Death | 2 | 2023 | 27 | 0.430 |
Why?
|
| Hydrocephalus | 3 | 2024 | 236 | 0.430 |
Why?
|
| Pregnancy, Triplet | 2 | 2022 | 10 | 0.410 |
Why?
|
| Lasers | 8 | 2024 | 115 | 0.400 |
Why?
|
| Fetal Blood | 2 | 2023 | 178 | 0.390 |
Why?
|
| Pulsatile Flow | 2 | 2021 | 133 | 0.370 |
Why?
|
| Airway Obstruction | 2 | 2023 | 165 | 0.360 |
Why?
|
| Treatment Outcome | 10 | 2024 | 12045 | 0.360 |
Why?
|
| Fetal Weight | 4 | 2023 | 52 | 0.340 |
Why?
|
| Lung | 5 | 2024 | 1476 | 0.330 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2023 | 158 | 0.290 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 2080 | 0.290 |
Why?
|
| Logistic Models | 3 | 2021 | 1772 | 0.280 |
Why?
|
| Laparotomy | 2 | 2024 | 136 | 0.270 |
Why?
|
| Trachea | 3 | 2023 | 197 | 0.260 |
Why?
|
| Infant | 7 | 2024 | 12302 | 0.260 |
Why?
|
| Prenatal Care | 3 | 2023 | 340 | 0.250 |
Why?
|
| Edema | 2 | 2023 | 133 | 0.250 |
Why?
|
| Postoperative Complications | 3 | 2021 | 2997 | 0.250 |
Why?
|
| Umbilical Cord | 2 | 2022 | 55 | 0.240 |
Why?
|
| Parvoviridae Infections | 1 | 2024 | 36 | 0.240 |
Why?
|
| Twins | 2 | 2021 | 68 | 0.230 |
Why?
|
| Placental Insufficiency | 1 | 2024 | 13 | 0.230 |
Why?
|
| Hernia, Umbilical | 1 | 2024 | 42 | 0.230 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2021 | 60 | 0.230 |
Why?
|
| Erythroblastosis, Fetal | 1 | 2023 | 27 | 0.220 |
Why?
|
| Carbon Dioxide | 2 | 2023 | 274 | 0.220 |
Why?
|
| Sutures | 1 | 2024 | 67 | 0.220 |
Why?
|
| Oligohydramnios | 1 | 2023 | 42 | 0.220 |
Why?
|
| Spina Bifida Cystica | 1 | 2024 | 35 | 0.220 |
Why?
|
| Urinary Tract | 1 | 2023 | 59 | 0.220 |
Why?
|
| Abruptio Placentae | 1 | 2022 | 17 | 0.210 |
Why?
|
| Balloon Occlusion | 1 | 2022 | 43 | 0.210 |
Why?
|
| Fetal Development | 2 | 2024 | 110 | 0.210 |
Why?
|
| Leptin | 1 | 2024 | 209 | 0.200 |
Why?
|
| Cytomegalovirus Infections | 1 | 2024 | 218 | 0.200 |
Why?
|
| Chorioamnionitis | 1 | 2022 | 41 | 0.200 |
Why?
|
| Placenta Diseases | 1 | 2022 | 58 | 0.200 |
Why?
|
| Tertiary Care Centers | 1 | 2023 | 231 | 0.200 |
Why?
|
| Intestinal Atresia | 1 | 2022 | 19 | 0.200 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2022 | 62 | 0.200 |
Why?
|
| Tocolytic Agents | 1 | 2021 | 12 | 0.200 |
Why?
|
| Maryland | 1 | 2021 | 28 | 0.200 |
Why?
|
| Middle Cerebral Artery | 1 | 2022 | 110 | 0.200 |
Why?
|
| Indomethacin | 1 | 2021 | 84 | 0.190 |
Why?
|
| Waist Circumference | 1 | 2021 | 84 | 0.190 |
Why?
|
| Hemangioma | 1 | 2022 | 97 | 0.190 |
Why?
|
| Respiratory System Abnormalities | 1 | 2022 | 42 | 0.190 |
Why?
|
| Patient Handoff | 1 | 2021 | 26 | 0.190 |
Why?
|
| Abortion, Spontaneous | 1 | 2022 | 85 | 0.190 |
Why?
|
| Rhabdoid Tumor | 1 | 2021 | 52 | 0.180 |
Why?
|
| Extraembryonic Membranes | 1 | 2020 | 14 | 0.180 |
Why?
|
| Simulation Training | 1 | 2022 | 139 | 0.180 |
Why?
|
| Uterine Rupture | 1 | 2020 | 18 | 0.180 |
Why?
|
| Incidence | 4 | 2021 | 3018 | 0.180 |
Why?
|
| Myometrium | 1 | 2020 | 48 | 0.180 |
Why?
|
| Organ Size | 2 | 2021 | 411 | 0.180 |
Why?
|
| Delphi Technique | 1 | 2021 | 200 | 0.180 |
Why?
|
| Catheters, Indwelling | 1 | 2021 | 156 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 3448 | 0.170 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2020 | 51 | 0.170 |
Why?
|
| Cervical Length Measurement | 1 | 2019 | 3 | 0.170 |
Why?
|
| Polytetrafluoroethylene | 1 | 2020 | 80 | 0.170 |
Why?
|
| alpha-Fetoproteins | 1 | 2021 | 136 | 0.170 |
Why?
|
| Gastroschisis | 1 | 2020 | 53 | 0.170 |
Why?
|
| Fetal Heart | 1 | 2020 | 111 | 0.170 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2024 | 440 | 0.170 |
Why?
|
| Polyhydramnios | 1 | 2019 | 51 | 0.170 |
Why?
|
| Cicatrix | 1 | 2020 | 125 | 0.160 |
Why?
|
| Twins, Conjoined | 1 | 2019 | 29 | 0.160 |
Why?
|
| Preoperative Care | 1 | 2021 | 350 | 0.160 |
Why?
|
| Siblings | 1 | 2019 | 191 | 0.160 |
Why?
|
| Papillary Muscles | 1 | 2018 | 19 | 0.160 |
Why?
|
| ROC Curve | 1 | 2020 | 552 | 0.160 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2018 | 6 | 0.160 |
Why?
|
| Delivery, Obstetric | 1 | 2021 | 253 | 0.160 |
Why?
|
| Steroids | 1 | 2019 | 203 | 0.160 |
Why?
|
| Light Coagulation | 3 | 2023 | 24 | 0.160 |
Why?
|
| Movement Disorders | 1 | 2021 | 219 | 0.160 |
Why?
|
| Travel | 1 | 2019 | 117 | 0.160 |
Why?
|
| Cannula | 1 | 2018 | 29 | 0.150 |
Why?
|
| Genetic Testing | 1 | 2024 | 978 | 0.150 |
Why?
|
| Lung Diseases | 1 | 2022 | 384 | 0.150 |
Why?
|
| Young Adult | 6 | 2021 | 8760 | 0.150 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2018 | 103 | 0.140 |
Why?
|
| Mass Screening | 1 | 2023 | 778 | 0.140 |
Why?
|
| Follow-Up Studies | 2 | 2024 | 5013 | 0.140 |
Why?
|
| Survival Rate | 1 | 2022 | 1997 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1679 | 0.140 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2018 | 193 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 437 | 0.140 |
Why?
|
| Anxiety | 1 | 2023 | 950 | 0.140 |
Why?
|
| Sepsis | 1 | 2021 | 472 | 0.140 |
Why?
|
| Mitral Valve | 1 | 2018 | 245 | 0.140 |
Why?
|
| Pedigree | 1 | 2019 | 1533 | 0.130 |
Why?
|
| Texas | 2 | 2021 | 3528 | 0.130 |
Why?
|
| Child, Preschool | 5 | 2024 | 13777 | 0.130 |
Why?
|
| Heart Ventricles | 1 | 2020 | 767 | 0.130 |
Why?
|
| Laparoscopy | 1 | 2021 | 502 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 1871 | 0.130 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2017 | 276 | 0.120 |
Why?
|
| Recurrence | 1 | 2018 | 1413 | 0.120 |
Why?
|
| Depression | 1 | 2023 | 1214 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 581 | 0.120 |
Why?
|
| Lung Volume Measurements | 2 | 2024 | 67 | 0.110 |
Why?
|
| Male | 6 | 2024 | 59522 | 0.110 |
Why?
|
| Peptide Fragments | 1 | 2017 | 745 | 0.110 |
Why?
|
| Hydrops Fetalis | 2 | 2023 | 75 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2021 | 1153 | 0.090 |
Why?
|
| Cervix Uteri | 2 | 2023 | 70 | 0.090 |
Why?
|
| Iatrogenic Disease | 2 | 2022 | 129 | 0.090 |
Why?
|
| Statistics, Nonparametric | 2 | 2021 | 421 | 0.090 |
Why?
|
| Child | 4 | 2023 | 24064 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2016 | 1463 | 0.090 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2021 | 79 | 0.080 |
Why?
|
| Birth Weight | 2 | 2022 | 334 | 0.080 |
Why?
|
| Age Factors | 1 | 2016 | 2777 | 0.080 |
Why?
|
| Hypertension | 1 | 2017 | 1274 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2021 | 1468 | 0.070 |
Why?
|
| Mutation | 1 | 2019 | 5734 | 0.070 |
Why?
|
| Tensile Strength | 1 | 2024 | 38 | 0.060 |
Why?
|
| Polyesters | 1 | 2024 | 40 | 0.060 |
Why?
|
| Materials Testing | 1 | 2024 | 73 | 0.060 |
Why?
|
| Heart Failure | 1 | 2017 | 2125 | 0.060 |
Why?
|
| Prognosis | 2 | 2024 | 4488 | 0.060 |
Why?
|
| Parturition | 1 | 2023 | 62 | 0.050 |
Why?
|
| Watchful Waiting | 1 | 2023 | 63 | 0.050 |
Why?
|
| Risk Factors | 3 | 2021 | 9902 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2023 | 230 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 262 | 0.050 |
Why?
|
| Duodenal Obstruction | 1 | 2022 | 14 | 0.050 |
Why?
|
| Dilatation | 1 | 2022 | 68 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2023 | 241 | 0.050 |
Why?
|
| Fetal Movement | 1 | 2021 | 14 | 0.050 |
Why?
|
| Clubfoot | 1 | 2021 | 19 | 0.050 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2021 | 43 | 0.050 |
Why?
|
| Perinatal Care | 1 | 2022 | 68 | 0.050 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2021 | 109 | 0.050 |
Why?
|
| Multilevel Analysis | 1 | 2020 | 8 | 0.050 |
Why?
|
| Encephalocele | 1 | 2021 | 51 | 0.050 |
Why?
|
| Placental Circulation | 1 | 2020 | 23 | 0.050 |
Why?
|
| Perinatal Mortality | 1 | 2020 | 42 | 0.040 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2020 | 50 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2021 | 356 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2020 | 233 | 0.040 |
Why?
|
| Transient Tachypnea of the Newborn | 1 | 2019 | 2 | 0.040 |
Why?
|
| Aftercare | 1 | 2021 | 145 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2022 | 279 | 0.040 |
Why?
|
| Pressure | 1 | 2019 | 128 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2020 | 197 | 0.040 |
Why?
|
| Resuscitation | 1 | 2022 | 240 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2019 | 215 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 744 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2020 | 755 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 650 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 2018 | 48 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2021 | 1234 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2021 | 380 | 0.040 |
Why?
|
| Thoracotomy | 1 | 2018 | 111 | 0.040 |
Why?
|
| Estradiol | 1 | 2019 | 534 | 0.040 |
Why?
|
| Rats | 1 | 2024 | 3657 | 0.040 |
Why?
|
| Estrogens | 1 | 2019 | 506 | 0.040 |
Why?
|
| Progesterone | 1 | 2019 | 624 | 0.040 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2019 | 184 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 468 | 0.030 |
Why?
|
| Curriculum | 1 | 2021 | 714 | 0.030 |
Why?
|
| Pre-Eclampsia | 1 | 2018 | 220 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2018 | 181 | 0.030 |
Why?
|
| Stents | 1 | 2022 | 864 | 0.030 |
Why?
|
| United States | 2 | 2021 | 10487 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 1034 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1575 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1158 | 0.030 |
Why?
|
| Proteins | 1 | 2019 | 1043 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2019 | 799 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2796 | 0.030 |
Why?
|
| Adolescent | 2 | 2022 | 18940 | 0.030 |
Why?
|
| Brain | 1 | 2024 | 2937 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 25640 | 0.020 |
Why?
|
| Animals | 1 | 2024 | 33721 | 0.010 |
Why?
|